Related Experiment Video
Updated: Jul 20, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Adverse effects of antiepileptic drugs on bone mineral density
Arzu Babayigit1, Eray Dirik, Ece Bober
1Department of Pediatrics, Division of Neurology, Dokuz Eylul University Medical Faculty, Izmir, Turkey. arbabyigit@yahoo.com
Insights
Long-term use of antiepileptic drugs like valproic acid, carbamazepine, and oxcarbazepine in children with epilepsy is linked to lower bone mineral density. These medications may affect bone metabolism, warranting further investigation.
Area of Science:
- Pediatric Endocrinology
- Neurology
- Pharmacology
Background:
- Epilepsy is a common neurological disorder in children.
- Antiepileptic drugs (AEDs) such as valproic acid, carbamazepine, and oxcarbazepine are standard treatments for epilepsy.
- Concerns exist regarding the long-term effects of AEDs on bone health in pediatric populations.
Purpose of the Study:
- To investigate the impact of valproic acid, carbamazepine, and oxcarbazepine on bone metabolism markers.
- To assess bone mineral density (BMD) in children with idiopathic epilepsy on long-term AED treatment.
- To compare biochemical bone markers and BMD between epileptic children on AEDs and healthy controls.
Main Methods:
- Cross-sectional study involving 68 children with idiopathic epilepsy on AEDs (carbamazepine, valproic acid, or oxcarbazepine) for over 1 year and 30 healthy controls.
- Blood samples analyzed for calcium, phosphorus, alkaline phosphatase, parathormone, and 25-hydroxyvitamin D.
- Bone mineral density measured using dual-energy x-ray absorptiometry (DXA).
Main Results:
- No significant differences in serum calcium, phosphorus, liver enzymes, or albumin between groups.
- Elevated serum alkaline phosphatase levels observed in the AED-treated patient group compared to controls.
- Significantly lower bone mineral density values in children receiving AEDs compared to healthy children.
Conclusions:
- Long-term treatment with valproic acid, carbamazepine, or oxcarbazepine is associated with reduced bone mineral density in children.
- AED therapy may negatively impact skeletal mineralization.
- Further research is needed to elucidate the precise mechanisms and long-term skeletal consequences of these AEDs in pediatric epilepsy.
Abstract:
The aim of this study is to determine the frequency of changes in biochemical markers of bone metabolism in children who are receiving valproic acid, carbamazepine, and oxcarbazepine. Thirty healthy children and 68 children with idiopathic epilepsy treated with either carbamazepine (n = 23), valproic acid (n = 31), or oxcarbazepine (n = 14) for more than 1 year were enrolled into the study. Blood samples were obtained in order to determine biochemical parameters (calcium, phosphorus, alkaline phosphates, parathormone, and 25-hydroxyvitamin D). Bone mineral density was measured with the dual-energy x-ray absorptiometry method. There were no significant differences in the serum concentrations of calcium, phosphorus, aspartate aminotransferase, alanine aminotransferase, and albumin levels between the four groups. However, serum alkaline phosphatase concentrations were higher in the patient group as compared with the control subjects. In patients receiving antiepileptic drugs, bone mineral density values were significantly lower than the healthy control group. In conclusion, long-term antiepileptic drug treatment either with valproic acid, carbamazepine, or with oxcarbazepine which has unknown effects on skeletal mineralization, induces a state of decreased bone mineral density.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Glutamate Antagonists
